KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $2.6 billion.

  • BioNTech SE's Total Current Liabilities fell 621.0% to $2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year decrease of 621.0%. This contributed to the annual value of $2.7 billion for FY2024, which is 2103.24% up from last year.
  • BioNTech SE's Total Current Liabilities amounted to $2.6 billion in Q3 2025, which was down 621.0% from $2.1 billion recorded in Q2 2025.
  • BioNTech SE's 5-year Total Current Liabilities high stood at $5.8 billion for Q3 2021, and its period low was $1.6 billion during Q1 2021.
  • Over the past 5 years, BioNTech SE's median Total Current Liabilities value was $2.6 billion (recorded in 2024), while the average stood at $2.9 billion.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 174358.25% in 2021, then tumbled by 6152.04% in 2023.
  • Over the past 5 years, BioNTech SE's Total Current Liabilities (Quarter) stood at $4.0 billion in 2021, then dropped by 24.42% to $3.0 billion in 2022, then fell by 26.0% to $2.2 billion in 2023, then grew by 21.03% to $2.7 billion in 2024, then fell by 3.64% to $2.6 billion in 2025.
  • Its Total Current Liabilities was $2.6 billion in Q3 2025, compared to $2.1 billion in Q2 2025 and $1.6 billion in Q1 2025.